奥精医疗科技股份有限公司自愿披露关于公司产品获得注册证的公告

Core Points - The company has received approval for its absorbable composite bone repair material medical device from the National Medical Products Administration, enhancing its product portfolio in the bone repair materials sector [1][2] - The product is classified as a Class III medical device, with a registration certificate valid from September 25, 2025, to September 24, 2030 [1] - The new product builds on existing technology, incorporating absorbable polyester materials to improve strength and degradation controllability while maintaining excellent biocompatibility and bone healing capabilities [1] Company Impact - The approval of the new product is expected to broaden the company's product offerings and support its overall market expansion in the domestic market [2] - The actual sales performance of the new product will depend on its competitive edge and market sales capabilities, making future operational performance difficult to predict [2]